{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T01:10:05Z","timestamp":1699578605341},"reference-count":11,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,6,28]],"date-time":"2007-06-28T00:00:00Z","timestamp":1182988800000},"content-version":"vor","delay-in-days":9431,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Pharma Physio"],"published-print":{"date-parts":[[1981,9]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>1. Homozygous Brattleboro rats with hereditary hypothalamic diabetes insipidus (DI) developed one\u2010kidney, one\u2010clip (1K\u20131C) and two\u2010kidney, one\u2010clip (2K\u20131C) Goldblatt renal hypertension.<\/jats:p><jats:p>2. However, the systolic blood pressure (SBP) in 1K\u20131C Brattleboro rats was significantly lower than in non\u2010DI hypertensive 1K\u20131C Long\u2010Evans (LE) rats.<\/jats:p><jats:p>3. Treatment with the synthetic antidiuretic analogue of vasopressin, DDAVP (l\u2010desamino\u20108\u2010D\u2010arginine vasopressin), increased the SBP in the DI rats to the same level as in 1K\u20131C Long\u2010Evans. This elevation of SBP was associated with increased extracellular fluid volume in the DI rats after DDAVP.<\/jats:p><jats:p>4. The results suggest that vasopressin is not essential for the development of renal hypertension but the absolute levels of blood pressure achieved in 1K\u20131C hypertension are volume\u2010dependent and thus influenced by the water\u2010retaining properties of vasopressin.<\/jats:p>","DOI":"10.1111\/j.1440-1681.1981.tb00760.x","type":"journal-article","created":{"date-parts":[[2007,6,29]],"date-time":"2007-06-29T05:27:20Z","timestamp":1183094840000},"page":"519-523","source":"Crossref","is-referenced-by-count":5,"title":["IMPORTANCE OF ANTIDIURETIC PROPERTIES OF VASOPRESSIN IN EXPERIMENTAL RENAL HYPERTENSION"],"prefix":"10.1111","volume":"8","author":[{"given":"R. L.","family":"Woods","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. I.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,6,28]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.34.4.505"},{"key":"e_1_2_1_3_1","first-page":"H361","article-title":"Vasopressin in the rat with spontaneous hypertension","volume":"235","author":"Crofton J.T.","year":"1978","journal-title":"American Journal of Physiology"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.1.1.31"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.2.4.424"},{"key":"e_1_2_1_6_1","first-page":"H426","article-title":"Central angiotensin Il\u2010induced responses in spontaneously hypertensive rats","volume":"232","author":"Hoffman W.E.","year":"1977","journal-title":"American Journal of Physiology"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01477456"},{"key":"e_1_2_1_8_1","first-page":"45s","article-title":"Vasopressin and malignant deoxycorticosterone hypertension in rats","volume":"51","author":"M\u00f6hring J.","year":"1976","journal-title":"Clinical Science and Molecular Medicine"},{"key":"e_1_2_1_9_1","first-page":"F260","article-title":"Vasopressor role of ADH in the pathogensis of malignant DOC hypertension","volume":"232","author":"M\u00f6hring J.","year":"1977","journal-title":"American Journal of Physiology"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.42.1.17"},{"key":"e_1_2_1_11_1","first-page":"251s","article-title":"The role of vasopressin in blood pressure control and in experimental hypertension","volume":"55","author":"Pullan P.T.","year":"1978","journal-title":"Clinical Science and Molecular Medicine"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00586073"}],"container-title":["Clinical and Experimental Pharmacology and Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1681.1981.tb00760.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1681.1981.tb00760.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:34:37Z","timestamp":1699576477000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1681.1981.tb00760.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,9]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1981,9]]}},"alternative-id":["10.1111\/j.1440-1681.1981.tb00760.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1681.1981.tb00760.x","archive":["Portico"],"relation":{},"ISSN":["0305-1870","1440-1681"],"issn-type":[{"value":"0305-1870","type":"print"},{"value":"1440-1681","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981,9]]}}}